A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
The initial presentation is typically unilateral vision loss, with central or paracentral scotoma. Approximately ... by sudden visual alterations in one eye with blurred vision, temporal or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback